Latini R, Bizzi A, Cini M, Veneroni E, Marchi S, Riva E
J Pharm Pharmacol. 1987 Jun;39(6):426-31. doi: 10.1111/j.2042-7158.1987.tb03414.x.
Four groups of rats were given amiodarone chronically at 25, 37.5, 50, 75 mg kg-1/12 h for 3 weeks; on day 21 the animals were killed and blood, plasma, heart, lung, liver and fat were collected and assayed for amiodarone and desethylamiodarone. Amiodarone plasma concentrations ranged from 0.74 to 4.68 micrograms mL-1 and desethylamiodarone from 0.08 to 2.05 micrograms mL-1. Plasma, blood and tissue concentrations of amiodarone and desethylamiodarone increased significantly with the dose. Blood/plasma and tissue/plasma partition ratios of amiodarone and desethylamiodarone increased significantly at the higher doses. Blood/plasma ratio was a good predictor of tissue/plasma ratios of amiodarone and its metabolite, except in fat. Total phospholipid concentrations in lung were correlated with amiodarone and desethylamiodarone concentrations in plasma, blood and lung.
将四组大鼠分别以25、37.5、50、75毫克/千克体重每12小时的剂量长期给予胺碘酮,持续3周;在第21天处死动物,收集血液、血浆、心脏、肺、肝脏和脂肪,检测其中胺碘酮和去乙基胺碘酮的含量。胺碘酮血浆浓度范围为0.74至4.68微克/毫升,去乙基胺碘酮为0.08至2.05微克/毫升。胺碘酮和去乙基胺碘酮的血浆、血液及组织浓度随剂量显著增加。在较高剂量下,胺碘酮和去乙基胺碘酮的血/浆及组织/浆分配比显著增加。除脂肪外,血/浆比是胺碘酮及其代谢物组织/浆比的良好预测指标。肺中总磷脂浓度与血浆、血液及肺中胺碘酮和去乙基胺碘酮浓度相关。